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Regulatory network analysis of Paneth cell
and goblet cell enriched gut organoids using
transcriptomics approaches†
A. Treveil, ‡ab P. Sudhakar,‡ac Z. J. Matthews,‡d T. Wrzesin´ski,a E. J. Jones,ab
J. Brooks,abde M. O¨lbei,ab I. Hautefort,a L. J. Hall,b S. R. Carding,bd U. Mayer,f
P. P. Powell,d T. Wileman,bd F. Di Palma,a W. Haerty*a and T. Korcsma´ros *ab
The epithelial lining of the small intestine consists of multiple cell types, including Paneth cells and
goblet cells, that work in cohort to maintain gut health. 3D in vitro cultures of human primary epithelial
cells, called organoids, have become a key model to study the functions of Paneth cells and goblet cells
in normal and diseased conditions. Advances in these models include the ability to skew differentiation
to particular lineages, providing a useful tool to study cell type specific function/dysfunction in the
context of the epithelium. Here, we use comprehensive profiling of mRNA, microRNA and long non-
coding RNA expression to confirm that Paneth cell and goblet cell enrichment of murine small intestinal
organoids (enteroids) establishes a physiologically accurate model. We employ network analysis to infer
the regulatory landscape altered by skewing differentiation, and using knowledge of cell type specific
markers, we predict key regulators of cell type specific functions: Cebpa, Jun, Nr1d1 and Rxra specific to
Paneth cells, Gfi1b and Myc specific for goblet cells and Ets1, Nr3c1 and Vdr shared between them. Links
identified between these regulators and cellular phenotypes of inflammatory bowel disease (IBD)
suggest that global regulatory rewiring during or after differentiation of Paneth cells and goblet cells
could contribute to IBD aetiology. Future application of cell type enriched enteroids combined with the
presented computational workflow can be used to disentangle multifactorial mechanisms of these cell
types and propose regulators whose pharmacological targeting could be advantageous in treating IBD
patients with Crohn’s disease or ulcerative colitis.
Introduction
Gut barrier integrity is critically important for efficient nutrient
absorption and maintenance of intestinal homeostasis1 and is
maintained by the combined action of the various cell types
lining the intestinal epithelium.2 These intestinal epithelial
cells serve to mediate signals between the gut microbiota and
the host innate/adaptive immune systems.3,4 Disruption of
epithelial homeostasis along with dysregulated immune
responses are some of the underlying reasons behind the
development of inflammatory bowel disease (IBD) such as
Crohn’s disease (CD) and ulcerative colitis (UC).5 Therefore, a
greater insight into the functions of intestinal cells will further
our understanding of the aetiology of inflammatory gut
conditions.
To date, various cell types have been identified in the intestinal
epithelium based on specific functional and gene expression
signatures. Paneth cells residing in the small intestinal crypts
of Lieberku¨hn help to maintain the balance of the gut micro-
biota by secreting anti-microbial peptides, cytokines and other
trophic factors.6 Located further up the intestinal crypts, goblet
cells secrete mucin, which aggregates to form the mucus layer,
which acts as a chemical and physical barrier between the
intestinal lumen and the epithelial lining.7 Both of these cell
populations have documented roles in gut-related diseases.8,9
Dysfunctional Paneth cells with reduced secretion of anti-
microbial peptides have been shown to contribute to the
pathogenesis of CD,10 while reduction in goblet cell numbers
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and defective goblet cell function has been associated with UC
in humans.11
Recent studies have employed single cell transcriptomics
sequencing of tissue samples to characterise the proportion
and signatures of different epithelial cell types in the intestines
of healthy and IBD patients.12–14 However, to provide deeper
insights into the role of specific cell populations (such as
Paneth cells and goblet cells) in IBD, in vitro models are
required for in depth testing and manipulation. Such models
can be used to study specific mechanisms of action, host-
microbe interactions, intercellular communication, patient
specific therapeutic responses and to develop new diagnostic
approaches. Due to ease of manipulation, observation and
analysis, organoid models, including small intestinal models
(enteroids), are increasingly used in the IBD field.15–17 Enteroid
cell culture systems employ growth factors to expand and
differentiate Lgr5+ stem cells into spherical models of the
small intestinal epithelia which recapitulate features of the
in vivo intestinal tissue.18–20 It has been shown that these
enteroids contain all the major cell types of the intestinal
epithelium, and exhibit normal in vivo functions.21 These
models, generated using intestinal tissue from mice, from
human patient biopsies or from induced pluripotent stem cells
(iPSCs), have proven particularly valuable for the study of
complex diseases which lack other realistic models and exhibit
large patient variability, such as IBD.22,23 Small molecule treatments
have been developed that skew the differentiation of enteroids
towards Paneth cell or goblet cell lineages, improving representation
of these cells within the enteroid cell population.24,25 Specifically,
differentiation can be directed towards the Paneth cell lineage
through the addition of DAPT, which inhibits notch signaling,
and CHIR99021, which inhibits GSK3b-mediated b-catenin
degradation. Enteroid cultures enriched in goblet cells can be
generated through the addition of DAPT and IWP-2, an inhibitor
of Wnt signaling.25 Whilst these methods do not present single
cell type resolution, they provide useful tools to study Paneth cell
and goblet cell populations in the context of the other major
epithelial cell types.26 A recent study by Mead et al. found that
Paneth cells from enriched enteroids more closely represent
their in vivo counterparts than those isolated from convention-
ally differentiated enteroids, based on transcriptomics, proteo-
mics and morphologic data.27 Furthermore, we have shown that
enteroids enriched for Paneth cells and goblet cells recapitulate
in vivo characteristics on the proteomics level28,29 and that they
are a useful tool for the investigation of health and disease
related processes in specific intestinal cell types.29
Nevertheless, the effect of Paneth cell and goblet cell enrich-
ment of enteroids on key regulatory landscapes has not been
extensively characterised. In this study, we comprehensively
profiled mRNAs, miRNAs and lncRNAs from mouse derived,
3D conventionally differentiated enteroids (control), Paneth cell
enriched enteroids (PCeE) and goblet cell enriched enteroids
(GCeE) to determine the extent to which these enteroids display
increased Paneth cell and goblet cell signatures. We applied a
systems-level analysis of regulatory interactions within the
PCeEs and GCeEs to further characterise the effect of cell type
enrichment and to predict key molecular regulators involved
with Paneth cell and goblet cell specific functions. This analysis
was carried out using interactions networks, which are a
primary method to collate, visualise and analyse biological
systems. These networks are a type of systems biology data
representation, which aids the interpretation of -omics read-
outs by contextualising genes/molecules of interest and identi-
fying relevant signalling and regulatory pathways.30,31 In the
presented analysis, the nodes of the interaction networks
represent genes/molecules of interest from the transcriptomics
data and the edges represent regulatory connections (molecular
interactions) between the nodes inferred from databases.
Studying regulatory interactions using interaction networks
has proven useful to uncover how cells respond to changing
environments at a transcriptional level, to prioritise drug
targets and to investigate the downstream effects of gene
mutations and knockouts.32–34
We used network approaches to interpret the PCeE and GCeE
transcriptomic data by integrating directed regulatory connec-
tions from resources containing transcriptional and post-
transcriptional interactions. This integrative strategy led us to
define regulatory network landscapes altered by Paneth cell and
goblet cell enrichment of enteroids, termed the network and
GCeE network, respectively (Fig. 1). By incorporating known
Paneth cell and goblet cell markers, we used these networks
to predict master regulators of Paneth cell and goblet cell
differentiation and/or maintenance in the enriched enteroids.
Furthermore, we highlighted varying downstream actions of
shared regulators between the cell types. This phenomenon,
called regulatory rewiring, highlights the importance of changes
in regulatory connections in the function and differentiation
of specific cell types. Taken together, we show that cell type
enriched enteroids combined with the presented network biology
workflow have potential for application to the study of epithelial
dysfunction and mechanisms of action of multifactorial diseases
such as IBD.
Results
Secretory lineages are over-represented in cell type enriched
enteroids compared to conventionally differentiated controls
We generated 3D self-organising enteroid cultures in vitro from
murine small intestinal crypts (Fig. S1, ESI†).18–20 In addition to
conventionally differentiated enteroids, we generated enteroids
enriched for Paneth cells and goblet cells using well-established
and published protocols, presented in detail in the Methods.20,25
Bulk transcriptomics data was obtained from each set of
enteroids to determine genes with differential expression
resulting from enteroid skewing protocols. Differentially
expressed genes were calculated by comparing the RNA expres-
sion levels (including protein coding genes, lncRNAs and
miRNAs) of enteroids enriched for Paneth cells or goblet cells
to those of conventionally differentiated enteroids. 4135 genes
were differentially expressed (absolute log2 fold changeZ1 and
false discovery rate r0.05) in the PCeE dataset, and 2889 were
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differentially expressed in the GCeE dataset (Fig. 2A–C and
Table S1, ESI†). The larger number of differentially expressed
genes (DEGs) in the PCeE data could be attributed to the highly
specialised nature of Paneth cells.35,36 The majority of the DEGs
were annotated as protein coding: 79% in the PCeE dataset and
84% in the GCeE dataset. In addition, we identified lncRNAs
(PCeE, 11%; GCeE, 9%) and miRNAs (PCeE, 4%; GCeE, 2%)
among the DEGs (Fig. 2B). Some of these DEGs were identified
in both the PCeE and the GCeE datasets, exhibiting the same
direction of change compared to the conventionally differen-
tiated enteroid data. In total, 1363 genes were found upregu-
lated in both the PCeE and the GCeE data, while 442 genes were
found downregulated in both datasets (Fig. 2C). This result
highlights considerable overlap between the results of skewing
enteroids towards Paneth cells and goblet cells, and can be
explained by the shared differentiation history and secretory
function of both Paneth cells and goblet cells.
Pathway analysis was employed to study functional associa-
tions of the DEGs (Fig. 2D). The PCeE-specific DEGs were
associated with a number of metabolic pathways, including
metabolism of vitamins and cofactors, pyruvate metabolism
and citric acid (TCA) cycle and cholesterol biosynthesis. On the
other hand, GCeE-specific DEGs were associated with the
cell cycle through pathways such as cell cycle checkpoints,
DNA replication and G1/S transition. Pathways associated with
the shared DEGs included transmission across chemical
synapses, integration of energy metabolism and a number
of pathways linked to hormones. As hormone functions are
characteristic of enteroendocrine cells, this analysis suggests
that enteroendocrine cells are enriched in both the PCeEs and
the GCeEs.
To validate the cell types present in the enteroids, the
expression of five previously reported major cell type specific
markers were investigated across the enteroids using transcript
Fig. 1 Schematic representation of the workflow used to infer and analyse regulatory network landscapes altered by Paneth cell and goblet cell
enrichment of enteroids. PCeE/GCeE network – Paneth cell enriched enteroid/goblet cell enriched enteroid network; TF – transcription factor; lncRNA
– long non-coding RNA; miRNA – microRNA; mRNA – messenger RNA; UC – ulcerative colitis; CD – Crohn’s disease.
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abundances and RNA differential expression results (Table S2
and Fig. S2, ESI†). The control enteroids and the cell type
enriched enteroids expressed all five investigated markers: Lgr5
(stem cells), ChgA (enteroendocrine cells), Muc2 (goblet cells),
Lyz1 (Paneth cells) and Vil1 (epithelial cells). We observed an
upregulation of Muc2, Lyz1 and ChgA and a downregulation of Lgr5
in PCeEs and GCeEs compared to the control enteroids, confirming
the more pronounced differentiated status of the enteroids.
Fig. 2 Differentially expressed genes in Paneth cell enriched enteroids (PCeEs) and goblet cell enriched enteroids (GCeEs) (compared to conventionally
differentiated enteroids). (A) Volcano plots showing log2 fold change and adjusted p value for each gene following differential expression analysis of
PCeEs (left) and GCeEs (right). Horizontal and vertical lines indicate the differential expression criteria cut offs (q valuer 0.05 and log2 fold changeZ|1|).
(B) Number of differentially expressed genes (DEGs). miRNA = microRNA; lncRNA = long non-coding RNA; genes annotated as ‘other’ include
pseudogenes and antisense genes. (C) Venn diagrams indicating the number of DEGs (passing the cut off criteria). (D) Top 10 Reactome pathways of the
50 most significant DEGs (by q value). (E) Enrichment of cell type specific marker genes in the DEG lists. Higher significance scores indicate greater
enrichment. Number of markers in DEG list out of the total number of markers shown below significance score. Also see Tables S1 and S4 (ESI†).
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In addition, a number of Paneth cell specific antimicrobial
peptide genes were differentially expressed in the PCeE dataset,
including Ang4, Reg3g, Pla2g2a and Defa2 (Table S3, ESI†). Some
of these genes were also differentially expressed in the GCeE
dataset but with smaller log fold change values, e.g. Lyz1 and
Ang4. Conversely, a number of goblet cell mucin related genes
(including Muc2 and Tff3) were differentially expressed in both
datasets although all genes exhibited a smaller increase in the
PCeEs (Table S2, ESI†). Therefore, using primary cell type
specific markers, antimicrobial peptide genes and mucin-
related genes, we show that the enteroids contain all major
cell types, and that Paneth cells are most upregulated in the
Fig. 3 Summary and cluster analysis of regulatory network for Paneth cell enriched enteroid (PCeE) and goblet cell enriched enteroid (GCeE) datasets.
(A) Summary of number of nodes and interactions in the whole PCeE (left) and GCeE (right) networks. Total number of each regulator type shown in red,
number of each target type shown in blue. In the targets pie-chart, mRNAs represent protein coding genes and proteins, miRNAs represent miRNAs
genes and lncRNAs represent lncRNA genes. Size of circles represents log10 (total unique regulators/targets). Bar chart represents the distribution of
interaction types in the networks (log10 scale). (B) Heatplot of Reactome pathways significantly associated (q valuer 0.05) with each cluster of the PCeE
(orange) and GCeE (purple) networks. Only the top 5 pathways shown for each group (or more where equal q values). Only the top 3 clusters had
significantly associated pathways. Clusters labelled with rank and cell type and colours match the colour of the cluster shown in (C and D). (C and D)
Visualisation of the PCeE and GCeE regulatory networks with their associated clusters. The cluster rank and score is given next to each cluster. Black
nodes in the whole networks represent nodes which were not found in any cluster, whereas coloured nodes represent the cluster which they are part of.
TF – transcription factor; miRNA – microRNA; lncRNA – long non-coding RNA. See Items S1, S2 and Table S5 (ESI†).
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PCeEs, while goblet cells are most upregulated in the GCeEs.
We also note that both differentiation methods resulted in
increases of other secretory cell types as well.
To further investigate secretory cell type specific signatures
of the enteroids, we measured enrichment of secretory lineages
in the upregulated DEG lists using additional marker genes of
Paneth cells, goblet cells and enteroendocrine cells. While all
tests were significant (hypergeometric model, q value r 0.05),
we identified greater enrichment of Paneth cell markers in the
PCeE DEG list and goblet markers in the GCeE DEG list
(Fig. 2E). This confirms that both enteroid enrichment proto-
cols were successful in increasing the proportion of their target
cell type, but also increased proportions of other secretory
lineages, albeit to a lesser extent (Table S4, ESI†). This observa-
tion confirms previous studies that these enteroid differentia-
tion protocols result in enteroendocrine enrichment in
addition to Paneth cell and goblet cell enrichment.25,28
In conclusion, we have used image-based validation, pathway
analysis and marker gene investigation to show successful
enrichment of target cell types in the PCeE’s and GCeE’s.
We also highlighted an additional increase in other secretory
lineages, particularly enteroendocrine cells, as a result of both
enrichment protocols.
Reconstruction of regulatory networks altered by enteroid
differentiation skewing
To gain an understanding of the regulatory changes occurring
when enteroids development is skewed, we applied a network
biology approach, and identified regulator–target relationships
within the DEG lists. First, we generated a large network of non-
specific molecular interactions known to occurr in mice, by
collating lists of published data (Table S6, ESI†). The resulting
network (termed the universal network) consisted of 1 383 897
unique regulatory interactions connecting 23 801 molecular
entities. All interactions within the network represent one
of the following types of regulation: TF–TG, TF–lncRNA,
TF–miRNA, miRNA–mRNA or lncRNA–miRNA. TF–TGs and
TF–lncRNAs make up the majority of the network at 77% and
11% of all interactions, respectively. Due to its non-specific
nature, this universal network contains many interactions not
relevant for the current biological context. In order to get a
clearer and valid picture of regulatory interactions occurring in
our enteroids, we used the universal network to annotate the
PCeE DEGs and GCeE DEGs with regulatory connections.
Combining these connections, we generated specific regulatory
networks for PCeEs and GCeEs, where every node is a DEG and
every interaction has been observed in mice previously.
In total, the PCeE network, generated using differential
expression data from the PCeEs compared to the conventionally
differentiated enteroids, contained 37 062 interactions connect-
ing 208 unique regulators with 3023 unique targets (Fig. 3A and
Item S1, ESI†). The GCeE network, generated using differential
expression data from the GCeEs compared to the convention-
ally differentiated enteroids, contained 19 171 interactions con-
necting 124 unique regulators with 2095 unique targets (Fig. 3A
and Item S1, ESI†). 15.7% of all interactions (8856 out of 56 234)
were shared between the PCeE and GCeE networks, however
the interacting molecular entities in these interactions (termed
nodes) did not all exhibit the same direction of differential
expression between the networks (comparing PCeE or the GCeE
data to the conventionally differentiated enteroid data). In each
of the enriched enteroid regulatory networks, a particular gene
was represented (as a node in the network) only once, but
may have been involved in multiple different interactions.
In different interactions, a single node could act either as a
regulator or as a target and in different molecular forms, for
example, as a lncRNA in one interaction and as a target gene in
another.
To further investigate the makeup of these networks, we
employed cluster analysis to identify highly interconnected
regions (possible regulatory modules) in the PCeE and GCeE
regulatory networks. Using the MCODE software,37 we identi-
fied five distinct clusters in the PCeE network and seven
distinct clusters in the GCeE networks. A total or 1314 nodes
are present in the PCeE network clusters and 698 in the GCeE
network clusters. Functional analysis identified Reactome
pathways38 associated with each of the modules. Significant
pathways (q value r 0.05) were identified only for the highest
ranked three modules from each network, with a total of
12 pathways shared between the PCeE and GCeE associated
clusters (out of 32 associated with the PCeE clusters and 42 with
the GCeE clusters) (Fig. 3B–D). Of particular note, the first
cluster of the GCeE network has associations with the endosomal/
vacuolar pathway and antigen presentation, the second cluster is
associated with the cell cycle. Of the PCeE clusters, the first cluster
is associated with a range of functions including nuclear receptor
transcription pathway, regulation of lipid metabolism and
senescence. The second is associated with response to metal ions
and endosomal/vacuolar pathway and the third with G alpha (i)
signalling events (Table S5, ESI†).
In conclusion, we have generated regulatory interaction
networks, including transcriptional and post-transcriptional
interactions, which illustrate the effect of skewing enteroid
differentiation towards Paneth cell and goblet cell lineages.
Identification of potential cell type specific master regulators
Through pathway and marker analysis we predicted that our
PCeE and GCeE datasets (i.e. DEG lists), and consequently our
regulatory networks, contain signatures from the cell type of
interest as well as additional noise from other secretory
lineages. To focus specifically on the cell type specific elements
of the networks, we used previously identified cell type specific
markers to extract predicted Paneth cell and goblet cell regu-
lators from our PCeE and GCeE networks. As cell type specific
markers represent genes performing functions specific to a
particular cell type, we expected that the regulators of these
marker genes will have an important role in determining the
function of said cell type. To identify these regulators, we
extracted from the PCeE and GCeE networks, all relevant cell
type specific markers and their direct regulators. These new
networks were termed the Paneth cell subnetwork and goblet
cell subnetwork respectively. The Paneth cell subnetwork
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contained 33 markers specific for Paneth cells with 62 possible
regulators. The goblet cell subnework contained 150 markers
with 63 possible regulators (Fig. 4 and Table S7, ESI†). Obser-
ving the ratio of regulators and markers, the Paneth cell
subnetwork had, on average, 1.88 regulators for each marker.
On the other hand, the goblet cell subnetwork exhibited only
0.42 regulators for each marker. The quantity of markers
identified in each subnetwork (33 in the Paneth network and
150 in the goblet network) correlates with the number of
marker genes identified by Haber et al.12 However, far fewer
regulators were identified in the goblet cell subnetwork
per marker than for the Paneth cell subnetwork. Whilst the
underlying reason for this discrepancy is unknown, it could
potentially be evidence of the complex regulatory environment
required to integrate and respond to the arsenal of signals
recognised by Paneth cells in comparison to goblet cells.35
Of the 95 marker regulators, we identified approximately
one-third (30/95) as present in both subnetworks (Fig. 4C).
Given that the markers are different between the cell types,
a regulator shared between the Paneth cell and goblet
cell subnetworks must show an altered pattern of regulatory
targeting in the two cell types. This phenomenon, referred to as
regulatory rewiring, often results in functional differences of
shared regulators in different environments39 – for example, in
this case, between the Paneth cells and goblet cells.
Further investigation of the distinct regulator–marker
interactions highlighted a gradient of regulator specificity.
We generated matrices to visualise the markers controlled by
each regulator in the goblet cell (Fig. 5A and C) and the Paneth
cell (Fig. 5B) subnetworks. Each coloured square indicates that
a marker (shown on the y-axis) is regulated by the corres-
ponding regulator (shown on the x-axis). Squares are coloured
blue if the associated regulator is shared between the Paneth
cell and goblet cell subnetworks and orange if they are specific
to one subnetwork. A collection of regulators (both subnetwork
specific and shared) appear to regulate large proportions of the
markers. For example, Ets1, Nr3c1 and Vdr regulate 450%
of the markers in both the Paneth cell and the goblet cell
subnetworks. Specific to the Paneth cell subnetwork, Cebpa,
Jun, Nr1d1 and Rxra regulate450% of the markers. Specific to
the goblet cell subnetwork, Gfi1b and Myc regulate 450%
of the markers. These regulators represent potential master
regulators of differentiation or maintenance of the given
cell types in the enriched enteroids. Referring back to the
highly-interconnected clusters identified in the PCeE and GCeE
networks (Fig. 3C and D), we find these predicted master
regulators in different clusters. In the PCeE network, Cebpa,
Nr1d1, Nr3c1 and Rxra are in cluster 1, Vdr is in cluster 2, Jun is
in cluster 3 and Ets1 is unclustered. In the GCeE network, Ets1
and Myc are in cluster 1, Nr3c1 and Vdr are in cluster 2 and
Gfi1b is in cluster 3. This suggests a wide range of central
functions are carried out by this group of regulators, with
possible divergence of roles between the Paneth cell and the
goblet cell. In contrast to the predicted master regulators,
regulators such as Mafk in the Paneth cell subnetwork and
Spdef in the goblet cell subnetwork regulate only one marker.
These regulators likely have more functionally specific roles.
Together, these results highlight potential regulators which
likely play key roles in specification and maintenance of Paneth
and goblet cells and their functions in cell type enriched
enteroids.
Regulators of cell type specific markers exhibit rewiring
between Paneth cells and goblet cells
Cell type specific markers, which carry out cell type specific
functions, are inherently different between the Paneth cell
and goblet cell subnetworks (mutually exclusive). Therefore,
the regulators observed in both Paneth cell and goblet cell
subnetworks (shared regulators) are expected to target different
marker genes. To do this, the regulators must have different
regulatory connections in the different cell types, a pheno-
menon termed ‘rewiring’.40 We extended the analysis to the
original regulatory networks (PCeE and GCeE networks) to
investigate whether any of the 30 identified shared regulators
are rewired between the whole PCeE and the GCeE networks,
and thus are highly likely to have different functions in the two
types of enriched enteroids as well as between Paneth and
goblet cells. To quantify rewiring of each of these regulators,
we observed their targets in the PCeE and GCeE networks using
the Cytoscape application, DyNet. DyNet assigns each regulator
a rewiring score depending on how different their targets are
between the two regulatory networks (Table S8, ESI†). Using
these rewiring scores, we identified the five most rewired
regulators (of 30) as Etv4, let-7e-5p, miR-151-3p, Myb and Rora.
Fig. 4 Regulator–marker subnetworks for Paneth cell and goblet cell
datasets. (A and B) Paneth cell (A) and goblet cell (B) subnetworks. Nodes
represent genes, transcription factors or RNAs and edges represent
directed physical regulatory connections. Regulators are shown in red
and pink. Cell type specific markers are shown in blue. (C) Summary of the
number of nodes present in both the subnetworks. Paneth cell data above
and goblet cell data below. Total number of each regulator type shown in
red, number of each target type shown in blue. Regulators have been
categorised based on their membership in the two subnetworks – shared
regulators are present in both networks. In the targets pie-chart, mRNAs
also represent protein coding genes. Size of circles represents log10 (total
unique regulators/targets). TF – transcription factor; miRNA – microRNA;
lncRNA – long non-coding RNA.
Molecular Omics Research Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
D
ec
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
/2
/2
02
0 
2:
21
:1
8 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Mol. Omics This journal is©The Royal Society of Chemistry 2019
Functional enrichment analysis was carried out on the targets
of these regulators to test whether the targets specific to the
PCeE and GCeE networks have different functions (hypergeo-
metric model, q value r 0.1) (Table S9, ESI†). Across all five
regulators the general trend indicated that targets specific to
the PCeE network are associated with metabolism; targets
specific to the GCeE network are associated with cell cycle
and DNA repair. As pathway analysis carried out on the enteroid
Fig. 5 Matrices of interactions between markers and their regulators in the Paneth cell and goblet cell subnetworks. Regulators on y-axis, markers
(regulator targets) on y-axis. Orange boxes indicate the interaction of a regulator and a marker where the regulator is only found in one of the two
subnetworks. Blue boxes signify that the regulator is found in both the Paneth cell and the goblet cell subnetworks. (A) All goblet cell markers12 and their
regulators in the goblet cell subnetwork. (B) All Paneth cell markers12 and their regulators in the Paneth cell subnetwork. (C) Sub-section of A showing the
markers (and their regulators) which have the most regulatory connections. Interactions in Table S7 (ESI†).
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DEGs (Fig. 2D) identified the same phenomenon, this suggests
that the rewired regulators could be key drivers of transcrip-
tional changes during the skewing of enteroid differentiation
towards Paneth cell or goblet cell lineages. In addition, given
that the strongest signal of enriched enteroids represents their
enriched cell type, we predict that these functions are key
features of Paneth cells and goblet cells in the enteroids, and
that the rewired regulators are important drivers of cell type
specific functions.
Looking at the regulators in more detail, the GCeE specific
targets of miR-151-3p, for example, are significantly enriched
in functions relating to antigen presentation, cell junction
organisation, Notch signalling and the calnexin/calreticulin
cycle. None of these functions are enriched in the shared or
PCeE targets. Of particular interest is the calnexin/calreticulin
cycle, which is known to play an important role in ensuring
proteins in the endoplasmic reticulum are correctly folded and
assembled.41 Dysfunction of protein folding and the presence
of endoplasmic reticulum stress are both associated with
IBD.42–44 Therefore, we predict that miR-151-3p plays a role
in the secretory pathway of goblet cells and could be an
interesting target for IBD research. In addition, different
functional profiles were also observed for the targets of Rora
in the PCeE and GCeE regulatory networks: targets present in
both networks are significantly associated with mitosis,
whereas those specific to the PCeE network are associated
with metabolism, protein localisation, nuclear receptor
transcription pathway, circadian clock and hypoxia induced
signalling. GCeE specific targets of Rora are connected to
Notch signalling, cell cycle and signalling by Rho GTPases
(associated with cell migration, adhesion and membrane
trafficking) and interferon.
Altogether these observations show that some of the regu-
lators of both Paneth cell and goblet cell marker genes have
different targets (with different associated functions) between
the PCeE and the GCeE networks. This suggests that regulatory
rewiring occurrs between Paneth cell and goblet cell types.
Evaluating the disease relevance of the subnetwork specific
master regulators
To investigate the function and relevance of the predicted
master regulators in IBD, we carried out three analyses: (1) a
literature search to check what is known about the identified
master regulators; (2) an enrichment analysis to evaluate the
disease relevant genes in the PCeE and GCeE networks and
among the targets of the predicted master regulators; and
finally, (3) a comparative analysis with human biopsy based
single cell dataset to confirm the relevance of the data we
identified PCeE and GCeE networks.
The literature search was carried out using the three groups
of predicted master regulators: those specific to the Paneth cell
markers (Cebpa, Jun, Nr1d1 and Rxra), those specific to the
goblet cell markers (Gfi1b and Myc) and those which appear to
regulate many of the markers of both cell types (Ets1, Nr3c1
and Vdr). We identified five genes (Ets1, Nr1d1, Rxra, Nr3c1 and
Vdr) with associations to inflammation, autophagy and/or
inflammatory bowel disease (IBD), as shown in Table 1. These
genes correspond to 71% (5/7) of the Paneth cell associated
master regulators and 60% (3/5) of the goblet cell associated
master regulators. Interestingly, four of these genes (all apart
from Ets1), encode nuclear hormone receptors.
Given the possible relationship between the identified
master regulators and IBD, we tested the potential of the PCeE
and GCeE regulatory networks to study the pathomechanisms
of CD or UC. We checked for the presence of known CD or UC
associated genes in the networks, using data from two studies
of single nucleotide polymorphisms (SNPs)67,68 and one study
of CD expression quantitative trait loci (eQTLs).69 Using hyper-
geometric significance tests, we found that the PCeE network
was significantly enriched in all tested lists: genes with UC
Table 1 Literature associations relating to autophagy, inflammation and IBD for putative master regulators
Putative master regulator Autophagy/inflammation/IBD associations Ref.
NR1D1 (REV-ERBa) Modulates autophagy and lysosome biogenesis in macrophages leading to antimycobacterial effects 45
SNP rs12946510 which has associations to IBD, acts as a cis-eQTL for NR1D1 46
NR3C1 (glucocorticoid
receptor)
Associations with cellular proliferation and anti-inflammatory responses 47
Exogenous glucocorticoids are heavily used as anti-inflammatory therapy for IBD 48 and 49
ATG16L1, an autophagy related gene, was down-regulated in patients who do not respond to
glucocorticoid treatment
50 and 51
Transcriptionally regulates NFKb1, a SNP affected gene in ulcerative colitis 52 and 53
VDR (vitamin D
receptor)
Regulates autophagy in Paneth cells through ATG16L1 – dysfunction of autophagy in Paneth
cells has been linked to Crohn’s disease
54 and 55
Induces antimicrobial gene expression in other cell lines 56 and 57
Specific polymorphisms in the VDR genes have been connected to increased susceptibility to IDB 58
A study looking at colonic biopsies of IBD patients observed reduced VDR expression compared
to healthy biopsies
59
Interacts with five SNP affected UC genes 60 and 61
RXRa (retinoid X
receptor alpha)
Heterodimerizes with VDR (see above) 62
ETS1 (ETS
proto-oncogene 1)
Important role in the development of hematopoietic cells and Th1 inflammatory responses 63 and 64
Angiogenic factors in the VEGF-Ets-1 cascades are upregulated in UC and downregulated in CD 65
IBD susceptibility gene 66
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associated SNPs (13/47, p o 0.005), genes with CD associated
SNPs (22/97, p o 0.005) and genes with CD associated eQTLs
(290/1607, p o 0.0001) (Tables S10–S12, ESI†). On the other
hand, we found that the GCeE network was significantly
enriched in genes with UC associated SNPs (10/47, p o 0.005)
but regarding CD, the genes with SNP associations were not
significantly enriched (12/97, p = 0.11) and the genes with qQTL
associations were enriched with a larger p value (p o 0.05)
(Tables S10–S12, ESI†).
Next we investigated whether any of the genes with UC or CD
associated SNPs acts as regulators in the PCeE and GCeE
networks. Of the genes with CD associated SNPs, one acts as
a regulator in each network. Similarly, two genes with UC
associated SNPs act as regulators in the networks. Specifically
regarding CD associated genes, in the PCeE network, the gene
Dbp regulates Bik, which encodes the BCL2 interacting killer, a
pro-apoptotic, death promoting protein. In the GCeE network,
Notch2 regulates Notch3 and Hes1. Specifically, regarding UC
associated genes, in the PCeE network, Hnf4a regulates 994
genes/RNAs including nine Paneth cell markers (Cd244a, Fgfrl1,
Clps, Habp2, Hspb8, Pnliprp1/2, Defb1, Mymx) and one other
gene with UC associated SNPs (Tnfsf15). Additionally, a gene
with UC associated SNPs, Nr5a2, was found in both the PCeE
and GCeE networks regulating 389 and 276 genes/RNAs respec-
tively. In the PCeE network Nr5a2 targets include 6 Paneth cell
markers (Cd244a, Copz2, Pnliprp1/2, Sntb1, Mymx). Ultimately,
the large number of targets of these regulatory UC associated
genes suggests they have wide ranging effects on the regulatory
network of Paneth and goblet cells. To further establish the
relevance of the inferred PCeE and GCeE networks, we also
found an over-representation of drug target associated genes in
both the PCeE and GCeE networks (2683/16223 and 1918/16223
respectively, p o 0.0001), highlighting their potential for the
study of therapeutic implications (Table S12, ESI†).
To investigate the link between predicted master regulators
and IBD, we observed whether the genes with UC and CD
associated SNPs are regulated by the predicted master regula-
tors in the PCeE and GCeE networks (Table S13, ESI†). Given
that Paneth cell dysregulation is classically associated with CD
and goblet cell dysregulation/depletion with UC,70 we focused
this analysis only on these pairings, examining CD genes
amongst targets of Paneth cell predicted master regulators,
and UC genes amongst targets of goblet cell predicted master
regulators. In the PCeE network, we found 21 (of 22) of the CD
genes were regulated by at least one of the seven Paneth cell
predicted master regulators, while the targets of these master
regulators were significantly enriched with CD genes in the
PCeE network (po 0.001). Similarly, we observed that all 10 UC
genes in the GCeE network were regulated by at least one of the
five goblet cell predicted master regulators, while the targets of
these master regulators were significantly enriched with UC
genes (p o 0.005).
To confirm the relevance of these predicted master regula-
tors in a human system, a similar analysis was carried out using
goblet cell differentially expressed genes from a recent single
cell study of human inflamed UC colon biopsies.13 Using the
top 100 differentially expressed genes, following conversion to
mouse Ensembl identifiers, 20 were found to be targeted by the
predicted goblet cell master regulators in the GCeE network.
This represents a significant enrichment amongst all master
regulator targets (p o 0.005) (Table S13, ESI†).
Ultimately, by integrating functional annotations obtained
through literature searches, we show that the Paneth cell and
goblet cell regulatory networks contain genes with direct and
indirect associations with IBD. Furthermore, we find that the
PCEe and GCeE networks and the targets of predicted master
regulators are enriched with IBD associated genes – this finding
is corroborated using human single cell data from UC colon
biopsies. Consequently, these networks and the workflow to
reconstruct and analyse them have great potential for the study
of IBD pathomechanisms in specific intestinal cell types.
Discussion
By generating and integrating cell type enriched enteroid
RNAseq datasets with regulatory networks, we characterised
the regulatory environment altered by differentiation skewing.
Through focusing on cell type specific markers, we used the
regulatory networks to predict master regulators of Paneth cells
and goblet cells and to highlight the role of regulatory rewiring
in cell differentiation. Given the relevance of Paneth cell
and goblet cell dysfunction in IBD, future application of cell
type enriched enteroids combined with our network analysis
workflow can be used to disentangle multifactorial mechanisms
of IBD.
Analysis using known cell type specific markers confirmed
that skewing differentiation of enteroids towards Paneth cells
or goblet cells results in an increase in the target cell signatures
at the transcriptomics level. In addition, signatures of entero-
endocrine cells were increased in both differentiation proto-
cols, albeit at a lower amount than the target cell type. This
finding correlates with previous investigations at both the
transcriptomic and proteomic levels25,27–29 and is likely due
to the shared differentiation pathways of these secretory cells.
Nevertheless, as enteroids contain a mixed population of cell
types by nature and because intercellular communication is key
to a functioning epithelium,19,71 the increased proportion of
non-targeted secretory lineages should not be an issue for the
application of these models to research. In fact, the enrichment
of specific cell types is beneficial for enteroid-based research to
increase the signal originating from a specific population of
cells and to provide a larger population of cells of interest for
downstream single cell analysis of enteroids, which is particu-
larly beneficial when studying rare populations such as Paneth
cells. This is valuable due to the lack of in vitromodels for long-
term culture of non-self-renewing small intestinal epithelial
cells.72,73 Specifically, the comparison of ‘omics data from a
cell type enriched enteroid to a conventionally differentiated
enteroid enables generation of cell type signatures with more
specificity than can be obtained otherwise – except through
single cell sequencing. Single cell sequencing, however, comes
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at a greater financial cost and provides lower coverage which
can be problematic for rare cell types and lowly expressed
RNAs. Furthermore, a number of previous studies have shown
that these cell type enriched enteroid models, which offer a
simplified and manipulatable version of the intestinal environ-
ment, are useful for the investigation of health and disease
related processes.26,28,29 It must be considered, however, that
through applying chemical inhibitors to enteroids to enrich
particular cell types, we may observe changes in gene expres-
sion which are related to the direct effects of the inhibitor but
not to differentiation. Due to the nature of the inhibitors, it
would be challenging to separate these effects. For example,
CHIR99021, which is used for enriching Paneth cells, is a direct
inhibitor of glycogen synthase kinase 3 (GSK-3). GSK-3 has a
role in many cellular pathways including cellular proliferation
and glucose regulation.74
Using a priori molecular interaction knowledge, we anno-
tated differentially expressed genes (cell type enriched enteroids
vs. conventionally differentiated enteroids) with regulatory
connections. Collecting all connections together generated
regulatory networks for the Paneth cell enriched enteroid
(PCeE) and goblet cell enriched enteroid (GCeE) datasets. This
approach to collating networks (regulatory or otherwise) has
been used for a wide variety of research aims, such as the
identification of genes functioning in a variety of diseases,75,76
the prioritisation of therapeutic targets77 and for a more general
understanding of gene regulation in biological systems.78,79 The
application of prior knowledge avoids the need for reverse engi-
neering/inference of regulatory network connections, which is
time consuming, computationally expensive and requires large
quantities of high quality data.80 To investigate the substructure
and functional associations of the generated PCeE and GCeE
regulatory networks we applied a clustering approach. The identi-
fied clusters represent collections of highly interconnected nodes,
which likely form regulatory modules. Functional analysis con-
firmed distinct functional associations between the clusters as
well as between the networks. The observation that less than half
of the network nodes exist in clusters is consistent with the view
that regulatory networks are hierarchical and scale free with most
genes exhibiting low pleiotropy.81,82
Given the observed additional increase in secretory lineages
based on the DEGs of the enriched organoids, we chose to use
cell type specific markers to extract interactions specific to
Paneth cells and goblet cells from the generated regulatory
networks. This enables further enrichment of Paneth cell and
goblet cell signatures and reduction in noise in the networks
due to the presence of other cell types in the enteroids. Using
this approach, we identified possible regulators of cell type
specific functions in Paneth cells and goblet cells. Some of
these regulators were predicted to be important in both cell
types, but exhibited differential targeting patterns between the
PCeE and the GCeE networks, indicating rewiring of regulators
between the cell types. This highlights apparent redundancy
and/or cooperation of regulators which control similar cell type
specific functions and shows the potential importance
of regulatory rewiring in the evolution of cell type specific
pathways and functions, something which has been shown
previously to occurr.83,84 Functional analysis of the targets of
the most rewired regulators (Etv4, let-7e-5p, miR-151-3p, Myb
and Rora) highlights an overrepresentation of metabolism
associated targets in the PCeE network and cell cycle associated
targets in the GCeE network. A similar result was observed
when functional analysis was carried out on genes with signifi-
cantly different expression levels between the cell type enriched
enteroids and the conventionally differentiated enteroids
(Fig. 2B). This suggests that transcriptional changes during
the skewing of enteroid differentiation could be driven by
rewired regulators and that these functions are key features
of Paneth cells and goblet cells in the enteroids. The latter is
supported by current understanding that Paneth cells rely on
high levels of protein and lipid biosynthesis for secretory
functions,85 and they play an important role in metabolically
supporting stem cells.86 Additionally, as terminally-differentiated
cells do not undergo cell division, this result suggests that
enteroid goblet cell signatures are derived from a large population
of semi-differentiated goblet-like cells, a phenomenon previously
observed in tissue sample based studies.13,87 Extension of our
workflow to single cell sequencing of enteroid cells could validate
these findings by providing greater cell type specificity. However,
these techniques pose further technical and economic
challenges.88,89 Specifically, a large number of organoids must
be sequenced to mitigate cellular complexity and batch hetero-
geneity and powerful, reproducible and accurate computational
pipelines are required to analyse such data.90
We predicted key regulators involved in differentiation or
maintenance of Paneth cells and goblet cells in the enteroids:
Cebpa, Jun, Nr1d1 and Rxra specific to Paneth cells, Gfi1b and
Myc specific for goblet cells and Ets1, Nr3c1 and Vdr shared
between them. Validation of these regulators poses significant
challenges due to their wide expression and broad function
range. If the master regulators are controlling differentiation as
opposed to cell function maintenance, evaluating lineage arrest
or delay can be carried out using a gene knockout or knock
down. However the effects of pleiotropy will significantly
hamper the results and such a study would require significant
follow-up studies. On the other hand, if key regulators were
predicted by applying the presented computational workflow to
condition-specific organoids compared to control organoids
(e.g. drug treated organoids vs. non-treated organoids), the
validation would be much simpler. Literature investigation
highlighted that many of the predicted master regulators,
particularly those associated with Paneth cells, have connec-
tions to autophagy, inflammation and IBD (Table 1). While
some of these associations are related to different cell types, we
assume that if a gene can contribute to a specific function in
one cell type it may also contribute in another. This finding
suggests that dysregulation of key cell master regulators could
contribute to IBD.
To further investigate this finding, we identified Crohn’s
disease (CD) and ulcerative colitis (UC) genes in the PCeE and
GCeE networks. We found that CD associated genes are more
strongly associated with the PCeE network than the GCeE
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network. Given that Paneth cell dysfunction is classically asso-
ciated with CD, this finding highlights the relevance of the
generated networks to the in vivo situation. In the PCeE net-
work one SNP associated CD gene, Dbp, acts as a regulator. Dbp,
encoding the D site binding protein, regulates Bik, which
encodes the BCL2 interacting killer, a pro-apoptotic, death
promoting protein. Interestingly, rate of apoptosis has been
implicated in IBD disease mechanisms91 and has been associated
with IBD drug response.92 Therefore, this finding highlights a
possible regulatory connection between CD susceptibility genes
and IBD pathology on a Paneth cell specific level. In the GCeE
network, the SNP associated CD gene Notch2 acts as a regulator
forNotch3 andHes1. It has been previously demonstrated that this
pathway can block glucocorticoid resistance in T-cell acute lym-
phoblastic leukaemia via NR3C1 (predicted master regulator).93
This is relevant to IBD given that glucocorticoids are a common
treatment for IBD patients.49 Furthermore, this pathway has been
previously associated with goblet cell depletion in humans94
commonly observed in IBD patients. Furthermore, we identified
a significant enrichment of UC associated genes in both the PCeE
and GCeE networks. The majority of UC associated genes identi-
fied in the networks (9/14) were present in both, suggesting that
genetic susceptibilities of UC do not have a Paneth cell or goblet
cell specific effect. Two of the identified UC associated genes
act as regulators in the networks (Nr5a2 and Hnf4a), targeting
hundreds of genes and thus suggesting a broad ranging effect on
the networks. Building on the identified literature associations of
predicted master regulators, we found that the targets of Paneth
cell master regulators are enriched with CD associated genes, and
the targets of the goblet cell master regulators are enriched with
UC associated genes. This finding was further illustrated using
UC associated goblet cell genes from a human biopsy study,13
highlighting the relevance of these findings in a human system.
Ultimately, the observation of IBD susceptibility genes in the
regulatory networks of these enteroids highlights possible appli-
cation of this model system to study disease regulation in specific
intestinal cell types, through understanding specific mechanistic
pathways.
We have shown how network biology techniques can be
applied to generate interaction networks representing the change
in regulatory environments between two sets of enteroids. Here
we presented this workflow, and by using transcriptomics data we
characterised the effect of Paneth cell and goblet cell differentia-
tion skewing protocols on enteroids. However. the described
workflow could be applied to a variety of ‘omics datasets and
enteroid conditions. For example, to test the response of enteroids
to external stimuli, such as bacteria, and on enteroids grown from
human-derived biopsies, enabling patient-specific experiments.
The application of further ‘omics data-types to the described
approach could generate amore holistic view of cellular molecular
mechanisms, including the ability to observe post-translational
regulation. In this study, we integrated miRNA and lncRNA
expression datasets, in addition to mRNA data, as thesemolecules
have been shown to perform critical regulatory and mediatory
functions in maintaining intestinal homeostasis.46,68,95 However,
only small proportions of the generated PCeE and the GCeE
networks contained miRNA and lncRNA interactions (Fig. 2B),
due to lack of published interaction information, particularly
from murine studies. Both the application of human enteroid
data and the future publication of high-throughput interaction
studies involving miRNAs and lncRNAs will improve the ability to
study such interactions. Nevertheless, these network approaches
are beneficial for contextualising gene lists through annotating
relevant signalling and regulatory pathways31 and we can use
them to represent and analyse current biological knowledge, to
generate hypotheses and to guide further research.
In conclusion, we described an integrative systems biology
workflow to compare regulatory landscapes between enteroids
from different conditions, incorporating information on
transcriptional and post-transcriptional regulation. We applied
the workflow to compare Paneth cell and goblet cell enriched
enteroids to conventionally differentiated enteroids and pre-
dicted Paneth cell and goblet cell specific regulators, which
could provide potential targets for further study of IBD mechan-
isms. Application of this workflow to patient derived organoids,
genetic knockout and/or microbially challenged enteroids,
alongside appropriate validation and single cell sequencing if
available, will aid discovery of key regulators and signalling
pathways of healthy and disease associated intestinal cell types.
Methods
Animal handling
C57BL/6J mice of both sexes were used for enteroid generation.
All animals were maintained in accordance with the Animals
(Scientific Procedures) Act 1986 (ASPA).
Small intestinal organoid culture
Murine enteroids were generated as described previously.18,20,29
Briefly, the entire small intestine was opened longitudinally,
washed in cold PBS then cut into B5 mm pieces. The intestinal
fragments were incubated in 30 mM EDTA/PBS for 5 minutes,
transferred to PBS for shaking, then returned to EDTA for
5 minutes. This process was repeated until five fractions had
been generated. The PBS supernatant fractions were inspected for
released crypts. The crypt suspensions were passed through a
70 mm filter to remove any villus fragments, then centrifuged at
300  g for 5 minutes. Pellets were resuspended in 200 ml phenol-
red free Matrigel (Corning), seeded in small domes in 24-well
plates and incubated at 37 1C for 20 minutes to allow Matrigel
to polymerise. Enteroid media containing EGF, Noggin and
R-spondin (ENR; (18)) was then overlaid. Enteroids were gener-
ated from three separate animals for each condition, generating
three biological replicates.
To chemically induce differentiation, on days two, five and
seven post-crypt isolation, ENR media was changed to include
additional factors for each cell type specific condition: 3 mM
CHIR99021 (Tocris) and 10 mM DAPT (Tocris) [Paneth cells];
2 mM IWP-2 (Tocris) and 10 mM DAPT [goblet and entero-
endocrine cells].25
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Small intestinal organoid immunofluorescence
On day eight post-crypt isolation, enteroids were fixed with 4%
paraformaldehyde (PFA; Sigma-Aldrich) for 1 hour at 4 1C prior
to permeabilization with 0.1% Triton X-100 (Sigma-Aldrich)
and incubated in blocking buffer containing 10% goat serum
(Sigma-Aldrich). Immunostaining was performed overnight at
4 1C using primary antibodies: mouse anti-E-cadherin (BD
Transduction Laboratories), rabbit anti-muc2 (Santa Cruz)
and rabbit anti-lysozyme (Dako), followed by Alexa Fluor-488
and -594 conjugated secondary antibodies (ThermoFisher
Scientific). DNA was stained with DAPI (Molecular Probes).
Images were acquired using a fluorescence microscope
(Axioimager.M2, equipped with a Plan-Apochromat 63/1.4
oil immersion objective) and analysed using ImageJ/FIJI V1.51.
RNA extraction
On day eight post-crypt isolation (allowing optimal cell type-
enrichment as previously shown),25 enteroids were extracted
from Matrigel (Corning, 356237) using Cell Recovery Solution
(BD Bioscience, 354253), rinsed in PBS and RNA was extracted
using miRCURY RNA Isolation Tissue Kit (Exiqon, 300115)
according to the manufacturer’s protocol.
Stranded RNA library preparation
The enteroid transcriptomics libraries were constructed using
the NEXTflext Rapid Directional RNA-Seq Kit (PerkinElmer,
5138-07) using the polyA pull down beads from Illumina TruSeq
RNA v2 library construction kit (Illumina, RS-122-2001) with the
NEXTflext DNA Barcodes – 48 (PerkinElmer, 514104) diluted to
6 mM. The library preparation involved an initial QC of the RNA
using Qubit DNA (Life technologies, Q32854) and RNA (Life
technologies, Q32852) assays as well as a quality check using
the PerkinElmer GX with the RNA assay (CLS960010). Ligated
products were subjected to a bead-based size selection using
Beckman Coulter XP beads (A63880). As well as performing a
size selection this process removed the majority of unligated
adapters. Prior to hybridisation to the flow cell the samples
were amplified to enrich for DNA fragments with adapter
molecules on both ends and to amplify the amount of DNA
in the library. The strand that was sequenced is the cDNA
strand. The insert size of the libraries was verified by running
an aliquot of the DNA library on a PerkinElmer GX using the
High Sensitivity DNA chip (PerkinElmer, CLS760672) and the
concentration was determined by using a High Sensitivity Qubit
assay and q-PCR. Libraries were then equimolar pooled and
checked by qPCR to ensure the libraries had the necessary
sequencing adapters ligated.
Small RNA library preparation
The small RNA libraries were made using the TruSeq Small
RNA Library Prep Kits (Illumina, 15004197), six-base indexes
distinguish samples and allow multiplexed sequencing and
analysis using 48 unique indexes (Set A: indexes 1–12 (Illumina,
RS-200-0012)), Set B: indexes 13–24 (Illumina, RS-200-0024), Set
C: indexes 25–36 (Illumina, RS-200-0036), Set D: indices 37–48
(Illumina, RS-200-0048)) (TruSeq Small RNA Library Prep Kit
Reference Guide (Illumina, 15004197 Rev.G)). The TruSeq Small
RNA Library Prep Kit protocol is optimised for an input of
1 mg of total RNA in 5 ml nuclease-free water or previously
isolated microRNA may be used as starting material (minimum
of 10–50 ng of purified small RNA). Total RNA is quantified
using the Qubit RNA HS Assay kit (ThermoFisher, Q32852) and
quality of the RNA is established using the Bioanalyzer RNA
Nano kit (Agilent Technologies, 5067-1511), it is recommended
that RNA with an RNA Integrity Number (RIN) valueZ8 is used
for these libraries as samples with degraded mRNA are also
likely to contain degraded small RNA.
Library purification combines using BluePippin cassettes
(Sage Science Pippin Prep 3% Cassettes Dye-Free (CDF3010),
set to collection mode range 125–160 bp) to extract the library
molecules followed by a concentration step (Qiagen MinElute
PCR Purification, 28004) to produce libraries ready for
sequencing. Library concentration and size are established
using HS DNA Qubit and HS DNA Bioanalyser. The resulting
libraries were then equimolar pooled and qPCR was performed
on the pool prior to clustering.
Stranded RNA sequencing on HiSeq 100PE
The final pool was quantified using a KAPA Library Quant Kit
(Roche, 07960140001), denatured in NaOH and combined with
HT1 plus a 1% PhiX spike at a final running concentration of
10 pM. The flow-cell was clustered using HiSeq PE Cluster Kit
v3 (Illumina, PE-401-3001) utilising the Illumina PE HiSeq
Cluster Kit V3 cBot recipe V8.0 method on the Illumina cBot.
Following the clustering procedure, the flow-cell was loaded
onto the Illumina HiSeq2000 instrument following the manu-
facturer’s instructions with a 101 cycle paired reads and a
7-cycle index read. The sequencing chemistry used was HiSeq
SBS Kit v3 (Illumina, FC-401-3001) with HiSeq Control Software
2.2.68 and RTA 1.18.66.3. Reads in bcl format were demulti-
plexed based on the 6 bp Illumina index by CASAVA 1.8,
allowing for a one base-pair mismatch per library, and converted
to FASTQ format by bcl2fastq.
Small RNA sequencing on HiSeq rapid 50SE
The final pool was quantified using a KAPA Library Quant Kit
(Roche, 07960140001), denatured in NaOH and combined with
HT1 plus a PhiX spike at a final running concentration of
20 pM. The libraries were hybridized to the flow-cell using
TruSeq Rapid Duo cBot Sample Loading Kit (Illumina, CT-403-
2001), utilising the Illumina RR_TemplateHyb_FirstExt_VR
method on the Illumina cBot. The flow-cell was loaded onto
the Illumina HiSeq2500 instrument following the manu-
facturer’s instructions with a 51-cycle single read and a 7 cycle
index read. The sequencing chemistry used was HiSeq SBS
Rapid Kit v2 (Illumina, FC-402-4022) with a single read cluster
kit (Illumina, GD-402-4002), HiSeq Control Software 2.2.68 and
RTA 1.18.66.3. Reads in bcl format were demultiplexed based
on the 6 bp Illumina index by CASAVA 1.8, allowing for a one
base-pair mismatch per library, and converted to FASTQ format
by bcl2fastq.
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Differentially expressed transcripts
The quality of stranded reads was assessed by FastQC software
(version 0.11.4).96 All reads coming from technical repeats were
concatenated together and aligned (in stranded mode, i.e. with
‘–rna-strandness RF’ flag) using HISAT aligner (version 2.0.5).97
Subsequently, a reference-based de novo transcriptome assem-
bly was carried out for each biological repeat and merged
together using StringTie (version 1.3.2) with following para-
meters: minimum transcript length of 200 nucleotides, mini-
mum FPKM of 0.1 and minimum TPM of 0.1.98,99 Coding
potential of each novel transcript was determined with CPC
(version 0.9.2) and CPAT (version 1.2.2).100,101 From the novel
transcripts, only non-coding transcripts (as predicted by both
tools) were included in final GTF file. Gene and transcript
abundances were estimated with kallisto (version 0.43.0).102
Sleuth (version 0.28.1) R library was used to perform differen-
tial gene expression.103 mRNAs and lncRNAs with an absolute
log2 fold change of 1 and q valuer0.05 were considered to be
differentially expressed.
The small RNA reads were analysed using the sRNAbench
tool within the sRNAtoolbox suite of tools.104 The barcodes
from the 50 end and adapter sequences from the 30 end were
removed respectively. Zero mismatches were allowed in detect-
ing the adapter sequences with a minimum adapter length set
at 10. Only reads with a minimum length of 16 and a read-count
of 2 were considered for further analysis. The mice miRNA
collection was downloaded from miRBase version 21.105 The
trimmed and length filtered reads were then mapped to
the mature version of the miRBase miRNAs in addition to the
annotated version of the mouse genome (version mm10).
No mismatches were allowed for the mapping. A seed length
of 20 was used for the alignment with a maximum number of
multiple mappings set at 10. Read-counts normalised after
multiple-mapping were calculated for all the libraries. The
multiple-mapping normalised read-counts from the corres-
ponding cell type enriched enteroids were compared against the
conventionally differentiated enteroids to identify differentially
expressed miRNAs in a pair-wise manner using edgeR.106 miRNAs
with an absolute log2 fold change of 1 and false discovery rate
r0.05 were considered to be differentially expressed.
Differentially expressed genes were grouped by their presence
in the PCeE dataset, the GCeE dataset or in both. Each group of
differentially expressed genes was tested for functional enrich-
ment (hypergeometric model, q valuer 0.1) based on Reactome
and KEGG annotations using the ReactomePA R package38,107–109
following conversion from mouse to human identifiers using
Inparanoid (v8).110,111
Enrichment of marker genes
Cell type specific marker gene lists were obtained a mouse
single cell sequencing survey.12 The cell type specific signature
genes for Paneth, goblet and enteroendocrine cell types were
obtained from the droplet-based and the plate-based methods.
Gene symbols were converted to Ensembl gene IDs using
bioDBnet db2db.112
Hypergeometric distribution testing was carried out using a
custom R script to measure enrichment of cell type specific
marker genes in the differentially upregulated gene sets.
To standardise the universal dataset, only markers which are
present in the output of the Wald test (genes with variance
greater than zero among samples) were used. Similarly, to
enable fair comparisons, only differentially expressed protein
coding genes and documented lncRNAs were used from the
DEG lists, as was surveyed in the cell type specific marker
paper. Bonferroni correction was applied to the hypergeometric
distribution p values to account for multiple testing and
significance scores were calculated using log10 (corrected
p value). For the mapping of marker genes to the interaction
networks, no filters were applied.
Reconstruction of molecular networks
Mice regulatory networks containing directed regulatory layers
were retrieved from multiple databases (Table S6, ESI†):
miRNA–mRNA (i.e., miRNAs regulating mRNAs) and lncRNA–
miRNA (i.e., lncRNAs regulating miRNAs) interactions were
downloaded from TarBase v7.0113 and LncBase v2.0,114 respec-
tively. Only miRNA–mRNA and lncRNA–miRNA interactions
determined using HITS-CLIP115 experiments were considered.
Regulatory interactions between transcription factors (TFs)
and miRNAs (i.e. TFs regulating miRNAs) were retrieved
from TransmiR v1.2,116 GTRD117 and TRRUST v2.118,119
Co-expression based inferences were ignored from all the above
resources. Transcriptional regulatory interactions (i.e., TFs
regulating target genes) were inferred using data from
ORegAnno 3.0,61 GTRD and TRUSST. In cases where transcrip-
tional regulatory interactions are derived from high-throughput
datasets such as ChIP-seq, we attributed the regulatory inter-
action elicited by the bound transcription factor to genes which
lie within a 10 kb window on either side of the ChIP-seq peak
(ORegAnno) or meta-cluster (in the case of GTRD). TF–lncRNA
interactions (i.e., TFs regulating lncRNAs) were also inferred
based on the ChIP-seq binding profiles represented by meta-
clusters in GTRD. We used only TF–lncRNA interactions within
intergenic lncRNAs to avoid assigning false regulatory inter-
actions due to the high number of instances where the lncRNAs
overlap with protein-coding genes. In addition, no overlaps
were allowed between the coordinates of the ChIP-seq peaks/
meta-clusters and any gene annotation. Only if the first annota-
tion feature within a 10 kb genomic window downstream to the
ChIP-seq peak/meta-cluster was designated as an intergenic
lncRNA, a regulatory interaction between the TF and the
lncRNA was assigned. Bedtools120 was used for the custom
analyses to look for overlaps between coordinates. All the nodes
in the collected interactions were represented by their Ensembl
gene IDs for standardization. A summary of the interactions
collected from each resource and the quality control criteria
applied is given in Table S6 (ESI†).
To generate PCeE and GCeE regulatory networks, inter-
actions in this collated universal network were filtered using
the differential expression data (Fig. 1). The assumption was
made that if both nodes of a particular interaction were
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expressed in the RNAseq data, the interaction is possible.
Furthermore, to filter for the interactions of prime interest,
only nodes which were differentially expressed and their asso-
ciated interactors were included in the regulatory networks.
Cluster analysis
Clusters of highly interconnected regions within the PCeE and
GCeE regulatory networks were identified using the MCODE
plugin within Cytoscape.37,121 Default settings were applied:
degree cutoff = 2, haircut = true, node score cutoff = 0.2, k-core = 2
and max depth = 100. Clusters were visualised in Cytoscape.
The nodes of each cluster were tested for functional enrich-
ment (hypergeometric model, q valuer 0.05) based on Reactome
annotations using the ReactomePA R package38,107–109 following
conversion from mouse to human identifiers using Inparanoid
(v8).110,111 Cases where the number of nodes associated with a
pathway o5 were considered not significant regardless of the
q value. The top 5 significant Reactome pathways associated with
each cluster were visualised using a heatplot generated in
R (Fig. 3B). More than 5 pathways were visualised, where multiple
Reactome pathways had equal q values.
Master regulator analysis
To identify potential master regulators of the Paneth cell and
the goblet cell types, the upstream regulators of cell type
specific markers (from ref. 12) were investigated. To do this,
all markers were mapped to the relevant networks then subnet-
works were extracted consisting of markers and their regulators
(Table S7, ESI†).
Regulatory rewiring analysis
To calculate rewiring scores for regulators, sub-networks were
extracted (from the PCeE and GCeE regulatory networks)
containing just the regulator of interest and its downstream
targets. For each regulator of interest, the subnetworks
from the PCeE and GCeE networks were compared using the
Cytoscape app DyNet.121,122 The degree corrected Dn score was
extracted for each regulator and used to quantify rewiring of the
regulator’s downstream targets between the PCeE and GCeE
regulatory networks. Functional analysis was carried out on the
targets of the top five most rewired regulators. For each
regulator, the targets were classified based on whether they
are present in only the PCeE network, only the GCeE network or
in both networks. Each group of targets was tested for func-
tional enrichment (hypergeometric model, q valuer 0.1) based
on Reactome and KEGG annotations using the ReactomePA R
package38,107–109 following conversion from mouse to human
identifiers using Inparanoid (v8).110,111
IBD and drug target associated genes
Genes associated with UC and CD based on single nucleotide
polymorphisms were obtained from two studies.67,68 Additionally,
the top 100 differentially expressed genes were obtained from
goblet cell analysis of inflamed UC vs. healthy human colonic
tissue from ref. 13. Genes were converted to Mouse Ensembl
identifiers using Inparanoid (v8) and bioDBnet db2db.110–112
Additionally, to enable hypergeometric significant testing with
the universal network as the background, only UC and CD
genes present in the universal network are included in the
analyses. eQTL datasets for CD were retrieved from ref. 69 while
the list of targets related to drug-interactions was downloaded
from ref. 123.
Quantification and statistical analysis
Statistical parameters including the exact value of n and
statistical significance are reported in the figures and figure
legends. n represents the number of enteroid biological
replicates generated. Where relevant, data is judged to be
statistically significant when Bonferroni corrected p value
r0.01. Genes with absolute log2 fold change ofZ|1| and false
discovery rate r0.05 were considered to be differentially
expressed. Based on principal component analysis of transcript
expression, one biological replicate from the Paneth cell
enriched enteroids was identified as an outlier and removed
(Fig. S3, ESI†). Where stated, the hypergeometric distribution
model was used to calculate significance using R.
Data and software availability
Small and stranded RNA-seq data has been deposited in the
European Nucleotide Archive (ENA) with accession numbers
PRJEB32354 and PRJEB32366 respectively. Scripts to analyse the
differentially expressed genes are available on GitHub: https://
github.com/korcsmarosgroup/organoid_regulatory_networks.
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